SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-20-010175
Filing Date
2020-04-29
Accepted
2020-04-29 17:22:05
Documents
36
Period of Report
2020-04-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm   iXBRL 8-K 27229
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 39564
6 ex99_1slide1.jpg GRAPHIC 78164
7 ex99_1slide2.jpg GRAPHIC 251495
8 ex99_1slide3.jpg GRAPHIC 160148
9 ex99_1slide4.jpg GRAPHIC 82155
10 ex99_1slide5.jpg GRAPHIC 78012
11 ex99_1slide6.jpg GRAPHIC 95755
12 ex99_1slide7.jpg GRAPHIC 82474
13 ex99_1slide8.jpg GRAPHIC 87738
14 ex99_1slide9.jpg GRAPHIC 95909
15 ex99_1slide10.jpg GRAPHIC 91548
16 ex99_1slide11.jpg GRAPHIC 102845
17 ex99_1slide12.jpg GRAPHIC 81910
18 ex99_1slide13.jpg GRAPHIC 80931
19 ex99_1slide14.jpg GRAPHIC 101174
20 ex99_1slide15.jpg GRAPHIC 131039
21 ex99_1slide16.jpg GRAPHIC 81093
22 ex99_1slide17.jpg GRAPHIC 125483
23 ex99_1slide18.jpg GRAPHIC 57452
24 ex99_1slide19.jpg GRAPHIC 136260
25 ex99_1slide20.jpg GRAPHIC 96230
26 ex99_1slide21.jpg GRAPHIC 86539
27 ex99_1slide22.jpg GRAPHIC 107129
28 ex99_1slide23.jpg GRAPHIC 21863
  Complete submission text file 0001140361-20-010175.txt   3399958

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sxt-20200429.xsd EX-101.SCH 4192
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sxt-20200429_lab.xml EX-101.LAB 22718
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sxt-20200429_pre.xml EX-101.PRE 16215
30 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 4084
Mailing Address 777 EAST WISCONSIN AVENUE MILWAUKEE WI 53202-5304
Business Address 777 EAST WISCONSIN AVENUE MILWAUKEE WI 53202-5304 4142716755
SENSIENT TECHNOLOGIES CORP (Filer) CIK: 0000310142 (see all company filings)

IRS No.: 390561070 | State of Incorp.: WI | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-07626 | Film No.: 20831784
SIC: 2860 Industrial Organic Chemicals
Office of Life Sciences